Advertisement
Home »

The prognostic role of lymphocyte to monocyte ratio (LMR) in patients with Myelodysplastic Neoplasms.

May 15, 2023

ABOUT THE CONTRIBUTORS

  • Chuanyang Lu

    Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huaian, People’s Republic of China.

    Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China.

    Qiuni Chen

    Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huaian, People’s Republic of China.

    Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China.

    Jiaxin Li

    Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huaian, People’s Republic of China.

    Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China.

    Chunling Wang

    Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huaian, People’s Republic of China.

    Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China.

    Liang Yu

    Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huaian, People’s Republic of China.

    Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of China.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement